Augmedix, Inc. reiterated earnings guidance for the second quarter and full year of 2024. Management continues to expect second quarter 2024 revenue to increase slightly sequentially from the first quarter of 2024, and second quarter 2024 GAAP gross margins to increase from the first quarter of 2024 by 50 to 100 basis points.

For the full year of 2024, management continues to expect revenue of approximately $52 to $55 million.